Fatty liver disease, also known as hepatic steatosis, is a condition characterized by the accumulation of fat in the liver cells. This buildup can lead to inflammation and damage to the liver over time, potentially progressing to more severe conditions such as non-alcoholic fatty liver disease (NAFLD) or even non-alcoholic steatohepatitis (NASH), which involves liver inflammation and may lead to cirrhosis or liver cancer if left untreated.
Several risk factors contribute to the development of fatty liver disease. These include obesity, insulin resistance, type 2 diabetes, high levels of triglycerides in the blood, and metabolic syndrome. Additionally, excessive alcohol consumption can also cause a form of fatty liver disease known as alcoholic fatty liver disease.
Diagnosing fatty liver disease typically involves a combination of medical history review, physical examination, blood tests to assess liver function and enzymes, imaging studies such as ultrasound, CT scan, or MRI, and sometimes a liver biopsy for definitive diagnosis.
Treatment for fatty liver disease primarily focuses on addressing the underlying causes and lifestyle modifications. This may include weight loss through a combination of diet and exercise, managing diabetes and high cholesterol levels, avoiding alcohol consumption, and medications to control underlying conditions if necessary. In more advanced cases, where there is significant liver damage or progression to NASH, more intensive medical therapy or even liver transplantation may be required.
At Gastrointestinal Specialists of Long Island, we prioritize early detection and comprehensive management of fatty liver disease. As part of our commitment to patient care, we offer state-of-the-art Fibroscan imaging technology. Fibroscan provides a non-invasive method for assessing liver health, helping us to accurately risk stratify patients and identify those who may benefit from medical therapy or closer monitoring. By integrating advanced diagnostic tools like Fibroscan into our practice, we strive to provide personalized care tailored to each patient's unique needs, ensuring the best possible outcomes for those affected by fatty liver disease.